Astellas Pharma Inc. (TYO:4503)

Astellas Pharma Revenue

In the fiscal year ending March 31, 2026, Astellas Pharma had annual revenue of 2.14T JPY with 11.87% growth. Astellas Pharma had revenue of 554.57B in the quarter ending March 31, 2026, with 20.74% growth.

• Revenue: 2.14T
• Revenue Growth: +11.87%
• P/S Ratio: 1.90
• Revenue / Employee: 156.80M
• Employees: 13,643
• Market Cap: 4.06T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.14T	226.92B	11.87%
Mar 31, 2025	1.91T	308.65B	19.25%
Mar 31, 2024	1.60T	85.05B	5.60%
Mar 31, 2023	1.52T	222.46B	17.16%
Mar 31, 2022	1.30T	46.64B	3.73%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 24, 2026

Data Sources Report a data error